{"id":"amrinone","rwe":[],"tags":[{"label":"amrinone","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"cGMP-inhibited 3',5'-cyclic phosphodiesterase A","category":"target"},{"label":"PDE3A","category":"gene"},{"label":"PDE3B","category":"gene"},{"label":"PDE4A","category":"gene"},{"label":"C01CE01","category":"atc"},{"label":"Active","category":"status"},{"label":"Decompensated cardiac failure","category":"indication"},{"label":"Sanofi Aventis Us","category":"company"},{"label":"Approved 1980s","category":"decade"},{"label":"Calcium Channel Blockers","category":"pharmacology"},{"label":"Calcium-Regulating Hormones and Agents","category":"pharmacology"},{"label":"Cardiotonic Agents","category":"pharmacology"},{"label":"Cardiovascular Agents","category":"pharmacology"},{"label":"Enzyme Inhibitors","category":"pharmacology"},{"label":"Membrane Transport Modulators","category":"pharmacology"},{"label":"Phosphodiesterase 3 Inhibitors","category":"pharmacology"},{"label":"Phosphodiesterase Inhibitors","category":"pharmacology"},{"label":"Protective Agents","category":"pharmacology"},{"label":"Vasodilator Agents","category":"pharmacology"}],"phase":"marketed","safety":{"commonSideEffects":[],"contraindications":["Aortic valve stenosis","Disease of liver","Hypertrophic cardiomyopathy","Hypokalemia","Hypovolemia","Idiopathic hypertrophic subaortic stenosis","Kidney disease","Low blood pressure","Myocardial infarction","Myocardial infarction in recovery phase","Pulmonic valve stenosis","Thrombocytopenic disorder"]},"trials":[],"aliases":[],"company":"Sanofi","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=amrinone","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:16:21.162927+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:16:27.958974+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=amrinone","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:16:28.623282+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL12856/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:16:29.080145+00:00"}},"allNames":"cartonic","offLabel":[],"synonyms":["inamrinone lactate","amrinone","cartonic","cordemcura","inamrinone","vesistol","wincoram"],"timeline":[{"date":"1984-07-31","type":"positive","source":"DrugCentral","milestone":"FDA approval (Sanofi Aventis Us)"}],"brandName":"Cartonic","ecosystem":[{"indication":"Decompensated cardiac failure","otherDrugs":[{"name":"dobutamine","slug":"dobutamine","company":""},{"name":"dopamine","slug":"dopamine","company":""},{"name":"furosemide","slug":"furosemide","company":"Sanofi Aventis Us"},{"name":"milrinone","slug":"milrinone","company":"Sanofi Aventis Us"}],"globalPrevalence":null}],"mechanism":{"target":"cGMP-inhibited 3',5'-cyclic phosphodiesterase A","novelty":"Follow-on","targets":[{"gene":"PDE3A","source":"DrugCentral","target":"cGMP-inhibited 3',5'-cyclic phosphodiesterase A","protein":"cGMP-inhibited 3',5'-cyclic phosphodiesterase A"},{"gene":"PDE3B","source":"DrugCentral","target":"cGMP-inhibited 3',5'-cyclic phosphodiesterase B","protein":"cGMP-inhibited 3',5'-cyclic phosphodiesterase B"},{"gene":"PDE4A","source":"DrugCentral","target":"Phosphodiesterase 4","protein":"cAMP-specific 3',5'-cyclic phosphodiesterase 4A"},{"gene":"PDE4B","source":"DrugCentral","target":"Phosphodiesterase 4","protein":"cAMP-specific 3',5'-cyclic phosphodiesterase 4B"},{"gene":"PDE4C","source":"DrugCentral","target":"Phosphodiesterase 4","protein":"cAMP-specific 3',5'-cyclic phosphodiesterase 4C"},{"gene":"PDE4D","source":"DrugCentral","target":"Phosphodiesterase 4","protein":"cAMP-specific 3',5'-cyclic phosphodiesterase 4D"},{"gene":"TTK","source":"DrugCentral","target":"Dual specificity protein kinase TTK","protein":"Dual specificity protein kinase TTK"}],"modality":"Small Molecule","drugClass":"amrinone","explanation":"","oneSentence":"","technicalDetail":"Cartonic (amrinone) is a non-selective inhibitor of cGMP-inhibited 3',5'-cyclic phosphodiesterase A (PDE3A), leading to an increase in intracellular cyclic AMP (cAMP) levels, which in turn enhances cardiac contractility and relaxation."},"commercial":{"launchDate":"1984","_launchSource":"DrugCentral (FDA 1984-07-31, SANOFI AVENTIS US)"},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/201","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=amrinone","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=amrinone","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T08:47:29.564516","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:16:30.995021+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"milrinone","drugSlug":"milrinone","fdaApproval":"1987-12-31","genericCount":16,"patentStatus":"Off-patent — generic available","relationship":"same-class"}],"genericName":"amrinone","indications":{"approved":[{"name":"Decompensated cardiac failure","source":"DrugCentral","snomedId":195111005,"regulator":"FDA"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"milrinone","brandName":"milrinone","genericName":"milrinone","approvalYear":"1987","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT06301880","phase":"PHASE3","title":"Effect of Topically-applied Milrinone or Nitroglycerin on Internal Mammary Artery Free Flow","status":"COMPLETED","sponsor":"Damascus University","startDate":"2022-01-01","conditions":["Internal Mammary Artery Syndrome","Vasodilation"],"enrollment":46,"completionDate":"2023-01-31"},{"nctId":"NCT04362527","phase":"PHASE3","title":"Milrinone Infusion for VAsospam Treatment in Subarachnoid hemoRrhage","status":"COMPLETED","sponsor":"University Hospital, Angers","startDate":"2020-08-10","conditions":["Vasospasm"],"enrollment":370,"completionDate":"2026-01-12"},{"nctId":"NCT07144267","phase":"NA","title":"Comparison of Milrinone and Epinephrine on TAPSE","status":"NOT_YET_RECRUITING","sponsor":"Mansoura University","startDate":"2026-03-01","conditions":["Cardiac Anaesthesia","Cardiopulmonary Bypass"],"enrollment":102,"completionDate":"2028-03-30"},{"nctId":"NCT05055830","phase":"","title":"Opportunistic PK/PD Trial in Critically Ill Children (OPTIC)","status":"RECRUITING","sponsor":"Duke University","startDate":"2021-10-05","conditions":["Cardiac Disease","Critically Ill","Children, Adult"],"enrollment":2000,"completionDate":"2028-10-30"},{"nctId":"NCT02951130","phase":"PHASE2","title":"Milrinone in Congenital Diaphragmatic Hernia","status":"COMPLETED","sponsor":"NICHD Neonatal Research Network","startDate":"2017-10-24","conditions":["Congenital Diaphragmatic Hernia","Persistent Pulmonary Hypertension of the Newborn","Hypoxemic Respiratory Failure","Pulmonary Hypoplasia"],"enrollment":66,"completionDate":"2025-05-19"},{"nctId":"NCT05450328","phase":"PHASE2","title":"Inhaled Milrinone and Epoprostenol for the Prevention of Difficult Cardiac Pulmonary Bypass Separation","status":"NOT_YET_RECRUITING","sponsor":"Montreal Heart Institute","startDate":"2025-11-01","conditions":["Right Heart Failure","Right Ventricular Dysfunction"],"enrollment":141,"completionDate":"2027-01-01"},{"nctId":"NCT07186062","phase":"","title":"Clinical Outcomes of Levosimendan Versus Dobutamine Versus Milrinone in Cases With Acute Decompensated Heart Failure With Impaired Renal Function","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2022-06-01","conditions":["Acute Decompensated Heart Failure (ADHF)","Cardiorenal Syndrome (CRS)"],"enrollment":60,"completionDate":"2024-06-01"},{"nctId":"NCT05700617","phase":"EARLY_PHASE1","title":"Cardiac Power Output in Cardiogenic Shock Patients","status":"RECRUITING","sponsor":"University of Chicago","startDate":"2023-07-06","conditions":["Heart Failure","Cardiogenic Shock"],"enrollment":5,"completionDate":"2026-06"},{"nctId":"NCT04484675","phase":"PHASE4","title":"Inhaled and Intravenous Milrinone in Patients With Severe Pulmonary Hypertension","status":"RECRUITING","sponsor":"Zagazig University","startDate":"2023-05-20","conditions":["Pulmonary Hypertension Due to Left Heart Disease"],"enrollment":38,"completionDate":"2025-05-10"},{"nctId":"NCT05267886","phase":"PHASE4","title":"CAPITAL DOREMI 2: Inotrope Versus Placebo Therapy for Cardiogenic Shock","status":"RECRUITING","sponsor":"Ottawa Heart Institute Research Corporation","startDate":"2022-03-05","conditions":["Shock, Cardiogenic"],"enrollment":346,"completionDate":"2026-12"},{"nctId":"NCT04278404","phase":"","title":"Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)","status":"RECRUITING","sponsor":"Duke University","startDate":"2020-03-05","conditions":["Coronavirus Infection (COVID-19)","Pulmonary Arterial Hypertension","Urinary Tract Infections in Children","Hypertension","Pain","Hyperphosphatemia","Primary Hyperaldosteronism","Edema","Hypokalemia","Heart Failure","Hemophilia","Menorrhagia","Insomnia","Pneumonia","Skin Infection","Arrythmia","Asthma in Children","Bronchopulmonary Dysplasia","Adrenal Insufficiency","Fibrinolysis; Hemorrhage","Attention Deficit Hyperactivity Disorder","Multisystem Inflammatory Syndrome in Children (MIS-C)","Kawasaki Disease","Coagulation Disorder","Down Syndrome"],"enrollment":5000,"completionDate":"2027-09"},{"nctId":"NCT05838846","phase":"PHASE2,PHASE3","title":"Inhaled Versus Intravenous Milrinone for Patients Undergoing Mitral Valve Replacement Surgery","status":"COMPLETED","sponsor":"Menoufia University","startDate":"2023-04-01","conditions":["Mitral Valve Replacement","Pulmonary Hypertension","Inhaled Milrinone","Intravenous Milrinone"],"enrollment":60,"completionDate":"2025-01-01"},{"nctId":"NCT02098629","phase":"PHASE2","title":"Concomitant Milrinone and Esmolol Treatment in Patients with Acute Myocardial Infarction","status":"COMPLETED","sponsor":"Shantou University Medical College","startDate":"2015-05","conditions":["Myocardial Reperfusion Injury"],"enrollment":25,"completionDate":"2024-12"},{"nctId":"NCT04282629","phase":"PHASE2","title":"Cerebral Hemodynamic Optimization by Milrinone to Prevent Delayed Cerebral Ischemia","status":"RECRUITING","sponsor":"University Hospital, Toulouse","startDate":"2021-07-25","conditions":["Aneurysmal Subarachnoid Hemorrhage"],"enrollment":234,"completionDate":"2025-07"},{"nctId":"NCT06562036","phase":"NA","title":"Efficacy of Milrinone With Sildenafil in Persistent Pulmonary Hypertension in Children","status":"COMPLETED","sponsor":"Muhammad Aamir Latif","startDate":"2023-12-01","conditions":["Persistent Pulmonary Hypertension of the Newborn"],"enrollment":42,"completionDate":"2024-05-31"},{"nctId":"NCT02232399","phase":"PHASE2","title":"Is Levosimendan Superior to Milrinone Regarding Acute Kidney Injury After Cardiac Surgery for Congenital Heart Disease?","status":"COMPLETED","sponsor":"Göteborg University","startDate":"2014-10-15","conditions":["Congenital Heart Defects"],"enrollment":72,"completionDate":"2017-04-25"},{"nctId":"NCT06077721","phase":"","title":"Milrinone on Right Ventricular Strain in Cardiac Surgery","status":"UNKNOWN","sponsor":"Konkuk University Medical Center","startDate":"2023-11-03","conditions":["Ischemic Heart Disease","Valvular Heart Disease"],"enrollment":41,"completionDate":"2024-12"},{"nctId":"NCT04153383","phase":"","title":"Milrinone on Cardiac Performance During Off-pump Coronary Artery Bypass Surgery","status":"UNKNOWN","sponsor":"Konkuk University Medical Center","startDate":"2024-09","conditions":["Ischemic Heart Disease"],"enrollment":20,"completionDate":"2024-12"},{"nctId":"NCT01571037","phase":"PHASE1","title":"Inhaled Milrinone Use in Patients Receiving HeartMate II LVAD: A Pilot Study","status":"COMPLETED","sponsor":"University of Nebraska","startDate":"2012-04-05","conditions":["End Stage Heart Disease","Right Ventricular Dysfunction"],"enrollment":10,"completionDate":"2014-02-21"},{"nctId":"NCT05999487","phase":"NA","title":"Dobutamine Versus Milrinone in Management of Critically Ill Low Cardiac Output Pediatric Patients at Cairo University Children's Hospital","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2023-10","conditions":["Dobutamine, Milrinone , Pediatrics , Low Cardiac Output"],"enrollment":40,"completionDate":"2024-05"},{"nctId":"NCT05122884","phase":"PHASE2","title":"Milrinone Versus Placebo in Patients With Septic Shock","status":"UNKNOWN","sponsor":"Mahidol University","startDate":"2021-12-01","conditions":["Septic Shock","Cardiac Output"],"enrollment":64,"completionDate":"2025-06"},{"nctId":"NCT05132153","phase":"PHASE4","title":"Effect of Nebulized Milrinone on Right Ventricular Hemodynamics in Adult Cardiac Surgery","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2021-10-17","conditions":["Anesthesia"],"enrollment":70,"completionDate":"2022-09-20"},{"nctId":"NCT03160846","phase":"","title":"The Inotrope Evaluation and Research Patient Registry","status":"COMPLETED","sponsor":"Coram Clinical Trials","startDate":"2014-08-25","conditions":["Heart Failure"],"enrollment":129,"completionDate":"2021-09-30"},{"nctId":"NCT05131867","phase":"PHASE2","title":"Management of Cerebral Vascular Spasm in Posttraumatic Subarachnoid Hemorrhage Using Combination Therapy","status":"COMPLETED","sponsor":"Zagazig University","startDate":"2021-11-24","conditions":["Oral Nimodipine","Milrinone","Vascular Spasm After Traumatic Subarachnoidhaemorrhage"],"enrollment":30,"completionDate":"2022-05-24"},{"nctId":"NCT01841177","phase":"PHASE2","title":"Evaluating Precision of Therapy - Milrinone","status":"COMPLETED","sponsor":"The Hospital for Sick Children","startDate":"2013-04","conditions":["Congenital Heart Disease"],"enrollment":52,"completionDate":"2020-08"},{"nctId":"NCT03207165","phase":"PHASE4","title":"Milrinone Versus Dobutamine in Critically Ill Patients","status":"COMPLETED","sponsor":"Ottawa Heart Institute Research Corporation","startDate":"2017-08-30","conditions":["Low Cardiac Output Syndrome","Cardiogenic Shock","Acute Coronary Syndrome","Pulmonary Edema"],"enrollment":192,"completionDate":"2020-06-12"},{"nctId":"NCT04391478","phase":"PHASE1","title":"Efficacy and Safety of Milrinone Versus Sildenafil in the Treatment of Neonates With Persistent Pulmonary Hypertension","status":"COMPLETED","sponsor":"Rania Ali El-Farrash","startDate":"2015-01","conditions":["Persistent Pulmonary Hypertension"],"enrollment":40,"completionDate":"2015-09"},{"nctId":"NCT02712788","phase":"PHASE2","title":"Milrinone in Addition to Hyperdynamic Therapy in the Treatment of Vasospasm Following Aneurysmal Subarachnoid Hemorrhage","status":"TERMINATED","sponsor":"Indiana University","startDate":"2016-04-18","conditions":["Cerebral Vasospasm"],"enrollment":4,"completionDate":"2018-05-03"},{"nctId":"NCT02726620","phase":"NA","title":"Decision Support for Intraoperative Low Blood Pressure","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2017-01-05","conditions":["Hypotension"],"enrollment":22435,"completionDate":"2018-12-29"},{"nctId":"NCT03855579","phase":"PHASE4","title":"Levosimendan Versus Milrinone in Off Pump CABG Surgery","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2019-03-06","conditions":["Hemodynamics"],"enrollment":60,"completionDate":"2019-09-10"},{"nctId":"NCT03823781","phase":"PHASE3","title":"Prophylactic Use of Milrinone After Congenital Heart Surgery in Infants","status":"UNKNOWN","sponsor":"Shanghai Children's Medical Center","startDate":"2019-02","conditions":["Low Cardiac Output Syndrome","Cardiac Surgical Procedures","Infant"],"enrollment":520,"completionDate":"2021-07"},{"nctId":"NCT01956006","phase":"PHASE1,PHASE2","title":"Pilot Study of Slow Release Oral Milrinone in Patients With Advanced Heart Failure","status":"COMPLETED","sponsor":"The Alfred","startDate":"2013-10-01","conditions":["Heart Failure"],"enrollment":26,"completionDate":"2018-05-10"},{"nctId":"NCT02640846","phase":"PHASE4","title":"Effects of Levosimendan, Milrinone and Norepinephrine on Left and Right Ventricular Function in Septic Shock","status":"UNKNOWN","sponsor":"Sahlgrenska University Hospital","startDate":"2015-12","conditions":["Septic Shock","Cardiomyopathy"],"enrollment":30,"completionDate":"2019-01"},{"nctId":"NCT02644057","phase":"PHASE2","title":"Dobutamaine Versus Milrinone in Cardiorenal Syndrome","status":"WITHDRAWN","sponsor":"Maimonides Medical Center","startDate":"2016-03","conditions":["Cardiorenal Syndrome"],"enrollment":0,"completionDate":"2016-09"},{"nctId":"NCT00543309","phase":"PHASE2","title":"Effects of Perioperative Nesiritide or Milrinone Infusion on Recovery From Fontan Surgery","status":"TERMINATED","sponsor":"John M Costello","startDate":"2007-10","conditions":["Heart Defects, Congenital"],"enrollment":106,"completionDate":"2013-07"},{"nctId":"NCT02730117","phase":"NA","title":"Furosemide Stress Test Guiding Initiation of Renal Replacement Therapy","status":"COMPLETED","sponsor":"Chulalongkorn University","startDate":"2016-03","conditions":["Acute Kidney Injury"],"enrollment":118,"completionDate":"2017-07"},{"nctId":"NCT02549066","phase":"NA","title":"Impact of CArdiopulmonary Bypass Flow on Renal Blood Flow, Function and OXygenation","status":"COMPLETED","sponsor":"Sahlgrenska University Hospital","startDate":"2016-01","conditions":["Complication of Extracorporeal Circulation","Kidney Circulation Disorder","Renal Function Disorder"],"enrollment":18,"completionDate":"2017-08"},{"nctId":"NCT02408003","phase":"NA","title":"Changes in Cardiac Deformation Following Physiologic Alterations and Inotropic Support.","status":"COMPLETED","sponsor":"Sahlgrenska University Hospital","startDate":"2014-03","conditions":["Heart Failure, Diastolic","Aortic Valve Stenosis","Monitoring, Physiologic","Physiology"],"enrollment":30,"completionDate":"2017-05"},{"nctId":"NCT01088997","phase":"NA","title":"Pharmacokinetic Study of Milrinone in Babies With Persistent Pulmonary Hypertension of the Newborn","status":"TERMINATED","sponsor":"Children's Hospital of Philadelphia","startDate":"2010-06","conditions":["Persistent Fetal Circulation Syndrome"],"enrollment":12,"completionDate":"2015-05"},{"nctId":"NCT02595541","phase":"PHASE1,PHASE2","title":"Oral Sildenafil and Intravenous Milrinone on Postoperative Pulmonary Hypertension","status":"COMPLETED","sponsor":"Assiut University","startDate":"2015-06","conditions":["Pulmonary Hypertension"],"enrollment":30,"completionDate":"2015-10"},{"nctId":"NCT00446017","phase":"PHASE3","title":"The Effects of Adrenaline and Milrinone in Patients With Myocardial Dysfunction After CABG","status":"COMPLETED","sponsor":"University of Luebeck","startDate":"2003-06","conditions":["Cardiac Output, Low"],"enrollment":60,"completionDate":"2007-04"},{"nctId":"NCT01849094","phase":"PHASE1,PHASE2","title":"Evaluating the Safety, Pharmacokinetics and Haemodynamic Effect of a Slow Release Oral Formulation of Milrinone","status":"COMPLETED","sponsor":"The Alfred","startDate":"2013-05","conditions":["Healthy","Heart Failure"],"enrollment":9,"completionDate":"2014-12"},{"nctId":"NCT00338455","phase":"PHASE2","title":"Natrecor (Nesiritide) in Transplant-Eligible Management of Congestive Heart Failure-TMAC","status":"TERMINATED","sponsor":"Scios, Inc.","startDate":"2006-09","conditions":["Congestive Heart Failure","Cardiac Transplantation","Renal Insufficiency","Renal Failure"],"enrollment":16,"completionDate":"2007-10"},{"nctId":"NCT00819377","phase":"PHASE2","title":"Milrinone Inhaled in Cardiac Surgery","status":"COMPLETED","sponsor":"Andre Denault","startDate":"2009-02","conditions":["Valvular Stenosis","Valvular Insufficiency","Hypertension, Pulmonary","Coronary Artery Disease"],"enrollment":124,"completionDate":"2012-12"},{"nctId":"NCT01725776","phase":"PHASE2","title":"Inhaled Milrinone in Cardiac Surgery","status":"COMPLETED","sponsor":"Montreal Heart Institute","startDate":"2006-12","conditions":["Pulmonary Hypertension"],"enrollment":40,"completionDate":"2012-06"},{"nctId":"NCT01621971","phase":"PHASE3","title":"Effect of Brief Nebulization of Milrinone on Pulmonary Arterial Pressure Before Cardiopulmonary Bypass on Mitral Valve Surgery Patients","status":"COMPLETED","sponsor":"Konkuk University Medical Center","startDate":"2003-01","conditions":["Pulmonary Hypertension","Mitral Regurgitation"],"enrollment":20,"completionDate":"2004-01"},{"nctId":"NCT01576094","phase":"PHASE1,PHASE2","title":"Two Inodilators Postsurgery in Neonates","status":"COMPLETED","sponsor":"Fundacion para la Investigacion Biomedica del Hospital Universitario la Paz","startDate":"2009-11","conditions":["Low Cardiac Output Syndrome"],"enrollment":20,"completionDate":"2010-11"},{"nctId":"NCT00695929","phase":"NA","title":"Levosimendan in Congenital Cardiac Surgery","status":"COMPLETED","sponsor":"Cliniques universitaires Saint-Luc- Université Catholique de Louvain","startDate":"2008-07","conditions":["Congenital Cardiovascular Defects","Low Cardiac Output Syndrome"],"enrollment":50,"completionDate":"2009-10"},{"nctId":"NCT00966745","phase":"NA","title":"Milrinone During Living Donor Hepatectomy","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2008-01","conditions":["Hepatectomy"],"enrollment":38,"completionDate":"2008-12"},{"nctId":"NCT00549107","phase":"PHASE2","title":"Prophylactic Use of Levosimendan Versus Milrinone in Open Heart Surgery in Infants","status":"UNKNOWN","sponsor":"Ludwig Boltzmann Gesellschaft","startDate":"2007-09","conditions":["Low Cardiac Output Syndrome"],"enrollment":40,"completionDate":""}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NUI":"N0000148678","MMSL":"11852","NDDF":"000616","UNII":"I229274Y5B","VUID":"4021234","CHEBI":"CHEBI:2686","VANDF":"4018237","INN_ID":"4310","RXNORM":"738","UMLSCUI":"C0002697","chemblId":"CHEMBL12856","ChEMBL_ID":"CHEMBL12856","KEGG_DRUG":"D00231","DRUGBANK_ID":"DB01427","PUBCHEM_CID":"3698","SNOMEDCT_US":"412411004","IUPHAR_LIGAND_ID":"7202","SECONDARY_CAS_RN":"75898-90-7","MESH_DESCRIPTOR_UI":"D000676"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[{"period":"1984-","companyName":"Sanofi","relationship":"Original Developer"}],"pharmacokinetics":{"source":"DrugCentral","halfLife":"2.0 hours","clearance":"8.9 mL/min/kg","bioavailability":"93%","fractionUnbound":"0.89%","volumeOfDistribution":"1.3 L/kg"},"publicationCount":906,"therapeuticAreas":["Cardiovascular"],"atcClassification":{"source":"DrugCentral","atcCode":"C01CE01","allCodes":["C01CE01"]},"biosimilarFilings":[],"originalDeveloper":"Sanofi Aventis Us","recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"Sanofi","companyId":"sanofi","modality":"Small Molecule","firstApprovalDate":"1984","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:16:30.995021+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}